CAS RN: 910332-89-7
Methyl 3-Methyl-4-oxotetrahydro-2H-pyran-3-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250511 |
500mg |
Out of stock |
5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g, 10g
- Available purity: >95%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 910332-89-7
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>95% |
1
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
>95% |
1
In Stock
|
Shenzhen |
Inquiry |
| 1g |
>95% |
1
In Stock
|
Shenzhen |
Inquiry |
| 5g |
>95% |
1
In Stock
|
Shanghai |
Inquiry |
| 10g |
>95% |
1
In Stock
|
Hong Kong |
Inquiry |
910332-89-7 / methyl 3-methyl-4-oxooxane-3-carboxylate
Standard CAS: 910332-89-7
Multi CAS: Yes
Basic Information
CAS
910332-89-7
Multi CAS
Yes
Molecular Formula
C8H12O4
Molecular Weight
172.180000
Exact Mass
172.073559
InChI
InChI=1S/C8H12O4/c1-8(7(10)11-2)5-12-4-3-6(8)9/h3-5H2,1-2H3
InChIKey
AJZICXLGVPFUJT-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
12
Fraction Csp3
0.75
Rotatable bonds
1
H-bond acceptors
4
Molar refractivity
40.57
TPSA
52.6
LogP / Solubility
WLOGP
0.16
MLOGP
0.13
Consensus LogP
0.1
Log S (ESOL)
-0.94
Class (ESOL)
Very soluble
Log S (Ali)
-1.08
Class (Ali)
Soluble
Log S (SILICOS-IT)
-1.03
Class (SILICOS-IT)
Soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.66
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2